Journal of Clinical Endocrinology and Metabolism
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Impact of a Gluten-Free Diet on Quality of Life and Health Perception in Patients With Type 1 Diabetes and Asymptomatic Celiac Disease.
106:e1984-e1992.
2021
-
Impaired Function and Altered Morphology in the Skeletal Muscles of Adult Men and Women with Type 1 Diabetes
2021
-
14-Day Ketone Supplementation Lowers Glucose and Improves Vascular Function in Obesity: A Randomized Crossover Trial.
106:e1738-e1754.
2021
-
Stuttering and Incident Type 2 Diabetes: A Population-Based Study of 2.2 Million Adolescents.
106:978-987.
2021
-
The Relationship Between Glucose Control and Cognitive Function in People With Diabetes After a Lacunar Stroke.
106:e1521-e1528.
2021
-
Diabetes, Brain Infarcts, Cognition, and Small Vessels in the Canadian Alliance for Healthy Hearts and Minds Study.
106:e891-e898.
2021
-
Sex/Gender Modifies the Association Between the MC4R p.Ile269Asn Mutation and Type 2 Diabetes in the Mexican Population.
106:e112-e117.
2021
-
Remission of Type 2 Diabetes Following a Short-term Intervention With Insulin Glargine, Metformin, and Dapagliflozin.
105:2532-2540.
2020
-
Causal Association of Haptoglobin With Obesity in Mexican Children: A Mendelian Randomization Study.
105:e2501-e2510.
2020
-
The Melanocortin 4 Receptor p.Ile269Asn Mutation Is Associated with Childhood and Adult Obesity in Mexicans.
105:e1468-e1477.
2020
-
Impact of Vertebral Fractures and Glucocorticoid Exposure on Height Deficits in Children During Treatment of Leukemia.
104:213-222.
2019
-
The Relationship Between the Score on a Simple Measure of Cognitive Function and Incident CVD in People With Diabetes: A Post Hoc Epidemiological Analysis From the ACCORD-MIND Study.
102:3218-3225.
2017
-
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic People.
102:2251-2257.
2017
-
Piloting a Remission Strategy in Type 2 Diabetes: Results of a Randomized Controlled Trial.
102:1596-1605.
2017
-
Attenuation of Resting but Not Load-Mediated Protein Synthesis in Prostate Cancer Patients on Androgen Deprivation.
102:1076-1083.
2017
-
Management of Hypoparathyroidism: Summary Statement and Guidelines.
101:2273-2283.
2016
-
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.
101:364-389.
2016
-
Cognitive Performance at Late Adolescence and the Risk for Impaired Fasting Glucose Among Young Adults.
100:4409-4416.
2015
-
Incident Vertebral Fractures in Children With Leukemia During the Four Years Following Diagnosis.
100:3408-3417.
2015
-
Dysglycemia and Cognitive Dysfunction and Ill Health in People With High CV Risk: Results From the ONTARGET/TRANSCEND Studies.
100:2682-2689.
2015
-
Sex Differences in the Effects of Weight Loss Diets on Bone Mineral Density and Body Composition: POUNDS LOST Trial.
100:2463-2471.
2015
-
Cancer-Related Worry in Canadian Thyroid Cancer Survivors.
100:977-985.
2015
-
The Choice of Normative Pediatric Reference Database Changes Spine Bone Mineral Density Z-Scores But Not the Relationship Between Bone Mineral Density and Prevalent Vertebral Fractures.
100:1018-1027.
2015
-
Effect of Odanacatib on BMD and Fractures: Estimates from Bayesian Univariate and Bivariate Meta-analyses.
99:3070-3079.
2014
-
Efficacy of Vitamin D Supplementation in Depression in Adults: A Systematic Review.
99:757-767.
2014
-
Empirically Based Composite Fracture Prediction Model From the Global Longitudinal Study of Osteoporosis in Postmenopausal Women (GLOW).
99:817-826.
2014
-
Erratum.
99:1096-1096.
2014
-
Endurance Training Modulates Intramyocellular Lipid Compartmentalization and Morphology in Skeletal Muscle of Lean and Obese Women.
98:4852-4862.
2013
-
The Endocrine Society Guidelines: When the Confidence Cart Goes Before the Evidence Horse.
98:3246-3252.
2013
-
Calcium and Vitamin D Intake and Mortality: Results from the Canadian Multicentre Osteoporosis Study (CaMos).
98:3010-3018.
2013
-
Skeletal Muscle Abnormalities in Girls and Adolescents With Turner Syndrome.
98:2521-2527.
2013
-
Two Weeks of Reduced Activity Decreases Leg Lean Mass and Induces “Anabolic Resistance” of Myofibrillar Protein Synthesis in Healthy Elderly.
98:2604-2612.
2013
-
Up-Regulation of the Complement System in Subcutaneous Adipocytes from Nonobese, Hypertriglyceridemic Subjects Is Associated with Adipocyte Insulin Resistance.
97:4742-4752.
2012
-
Diets Higher in Dairy Foods and Dietary Protein Support Bone Health during Diet- and Exercise-Induced Weight Loss in Overweight and Obese Premenopausal Women.
97:251-260.
2012
-
Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk.
96:1727-1736.
2011
-
Childhood Obesity Is Associated with Shorter Leukocyte Telomere Length.
96:1500-1505.
2011
-
Modified-Release Recombinant Human TSH (MRrhTSH) Augments the Effect of131I Therapy in Benign Multinodular Goiter: Results from a Multicenter International, Randomized, Placebo-Controlled Study.
96:1368-1376.
2011
-
Association of 25(OH)D and PTH with Metabolic Syndrome and Its Traditional and Nontraditional Components.
96:168-175.
2011
-
Association of Hematological Parameters with Insulin Resistance and beta-Cell Dysfunction in Nondiabetic Subjects (vol 94, pg 3824, 2009).
95:5465-5465.
2010
-
Association of hematological parameters with insulin resistance and β-cell dysfunction in nondiabetic subjects (Journal of Clinical Endocrinology and Metabolism (2009) 94, (3824-3832)).
95:5465.
2010
-
Prenatal Determinants of Uterine Volume and Ovarian Reserve in Adolescence.
94:4931-4937.
2009
-
Skeletal Muscle Lipogenic Protein Expression Is Not Different between Lean and Obese Individuals: A Potential Factor in Ceramide Accumulation.
94:5053-5061.
2009
-
Association of Hematological Parameters with Insulin Resistance and β-Cell Dysfunction in Nondiabetic Subjects.
94:3824-3832.
2009
-
The Relationship between Maternal and Umbilical Cord Androgen Levels and Polycystic Ovary Syndrome in Adolescence: A Prospective Cohort Study.
94:3714-3720.
2009
-
Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Third International Workshop.
94:335-339.
2009
-
Surgery for Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop.
94:366-372.
2009
-
The Diagnosis and Management of Asymptomatic Primary Hyperparathyroidism Revisited.
94:333-334.
2009
-
Early Responsiveness of Women with Osteoporosis to Teriparatide After Therapy with Alendronate or Risedronate.
93:3785-3793.
2008
-
Quality of Reporting of Randomized Controlled Trials in General Endocrinology Literature.
93:3810-3816.
2008
-
Beneficial Effects of Propylthiouracil plusl-Thyroxine Treatment in a Patient with a Mutation inMCT8.
93:2084-2088.
2008
-
A Case for Clarity, Consistency, and Helpfulness: State-of-the-Art Clinical Practice Guidelines in Endocrinology Using the Grading of Recommendations, Assessment, Development, and Evaluation System.
93:666-673.
2008
-
Genetic Study of the Melanin-Concentrating Hormone Receptor 2 in Childhood and Adulthood Severe Obesity.
92:4403-4409.
2007
-
Absence of Stabilizing Mutations of β-Catenin Encoded by CTNNB1 Exon 3 in a Large Series of Sporadic Parathyroid Adenomas.
92:1564-1566.
2007
-
Age at Menarche: Influences of Prenatal and Postnatal Growth.
92:46-50.
2007
-
The Suppressor of Cytokine Signaling 3 Inhibits Leptin Activation of AMP-Kinase in Cultured Skeletal Muscle of Obese Humans.
91:3592-3597.
2006
-
Adiponectin, Adiposity, and Insulin Resistance in Children and Adolescents.
91:2119-2125.
2006
-
TheINSVNTR Locus Does Not Associate with Smallness for Gestational Age (SGA) but Interacts with SGA to Increase Insulin Resistance in Young Adults.
91:2437-2440.
2006
-
Erratum: 17β-estradiol supplementation decreases glucose rate of appearance and disappearance with no effect on glycogen utilization during moderate intensity exercise in men (Journal of Clinical Endocrinology and Metabolism (2005) 90 (6218-6229)).
91:1217.
2006
-
Efficacy of a Long-Acting Growth Hormone (GH) Preparation in Patients with Adult GH Deficiency.
90:6431-6440.
2005
-
17β-Estradiol Supplementation Decreases Glucose Rate of Appearance and Disappearance with No Effect on Glycogen Utilization during Moderate Intensity Exercise in Men.
90:6218-6225.
2005
-
Estrogen Supplementation Reduces Whole Body Leucine and Carbohydrate Oxidation and Increases Lipid Oxidation in Men during Endurance Exercise.
90:3592-3599.
2005
-
Impact of Growth Hormone Supplementation on Adult Height in Turner Syndrome: Results of the Canadian Randomized Controlled Trial.
90:3360-3366.
2005
-
Impaired Activation of AMP-Kinase and Fatty Acid Oxidation by Globular Adiponectin in Cultured Human Skeletal Muscle of Obese Type 2 Diabetics.
90:3665-3672.
2005
-
Is Glutamate Decarboxylase 2 (GAD2) a Genetic Link between Low Birth Weight and Subsequent Development of Obesity in Children?.
90:2384-2390.
2005
-
AMP-Activated Protein Kinase Is Not Down-Regulated in Human Skeletal Muscle of Obese Females.
89:4575-4580.
2004
-
A Systematic Review and Metaanalysis of the Effectiveness of Radioactive Iodine Remnant Ablation for Well-Differentiated Thyroid Cancer.
89:3668-3676.
2004
-
Alendronate in Primary Hyperparathyroidism: A Double-Blind, Randomized, Placebo-Controlled Trial.
89:3319-3325.
2004
-
The Economic Implications of Three Biochemical Screening Algorithms for Pheochromocytoma.
89:2859-2866.
2004
-
Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Placebo-Controlled Trial.
89:2048-2056.
2004
-
Authors’ Response: Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine.
89:1487-1487.
2004
-
Dosage Recommendations for Combination Regimen of Thyroxine and 3,5,3′-Triiodothyronine.
89:1486-1487.
2004
-
Does a Combination Regimen of Thyroxine (T4) and 3,5,3′-Triiodothyronine Improve Depressive Symptoms Better Than T4Alone in Patients with Hypothyroidism? Results of a Double-Blind, Randomized, Controlled Trial.
88:4551-4555.
2003
-
A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines.
88:553-558.
2003
-
Expression of Prostaglandin I2Synthase, but Not Prostaglandin E Synthase, Changes in Myometrium of Women at Term Pregnancy.
87:5274-5282.
2002
-
A Randomized Double-Blind Trial to Compare the Efficacy of Teriparatide [Recombinant Human Parathyroid Hormone (1–34)] with Alendronate in Postmenopausal Women with Osteoporosis.
87:4528-4535.
2002
-
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial.
87:3609-3617.
2002
-
Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical Trial.
87:3609-3617.
2002
-
Differential Changes in 15-Hydroxyprostaglandin Dehydrogenase and Prostaglandin H Synthase (Types I and II) in Human Pregnant Myometrium.
87:1345-1352.
2002
-
Differential Changes in 15-Hydroxyprostaglandin Dehydrogenase and Prostaglandin H Synthase (Types I and II) in Human Pregnant Myometrium.
87:1345-1352.
2002
-
Dermopathy of Graves’ Disease (Pretibial Myxedema): Long-Term Outcome.
87:438-446.
2002
-
Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration.
86:5148-5151.
2001
-
Sudden Enlargement of Local Recurrent Thyroid Tumor after Recombinant Human TSH Administration.
86:5148-5151.
2001
-
Efficacy of Ultrasound-Guided Fine-Needle Aspiration Biopsy in the Diagnosis of Complex Thyroid Nodules.
86:4089-4091.
2001
-
Efficacy of Ultrasound-Guided Fine-Needle Aspiration Biopsy in the Diagnosis of Complex Thyroid Nodules.
86:4089-4091.
2001
-
Oral Cholecystographic Agents and the Thyroid.
86:1853-1860.
2001
-
Oral Cholecystographic Agents and the Thyroid.
86:1853-1860.
2001
-
Leptin Production and Release in the Dually in VitroPerfused Human Placenta.
85:4298-4301.
2000
-
Leptin Production and Release in the Duallyin VitroPerfused Human Placenta1.
85:4298-4301.
2000
-
Detection of Endocrine-Disrupting Chemicals in Samples of Second Trimester Human Amniotic Fluid.
85:2954-2957.
2000
-
Lack of Sex Difference in Cerebrospinal Fluid (CSF) Leptin Levels and Contribution of CSF/Plasma Ratios to Variations in Body Mass Index in Children.
84:3021-3024.
1999
-
Lack of Sex Difference in Cerebrospinal Fluid (CSF) Leptin Levels and Contribution of CSF/Plasma Ratios to Variations in Body Mass Index in Children.
84:3021-3024.
1999
-
Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1-31)NH2 and hPTH-(1-34) in Healthy Humans.
84:2739-2743.
1999
-
Comparison of the Biochemical Responses to Human Parathyroid Hormone-(1–31)NH2and hPTH-(1–34) in Healthy Humans1.
84:2739-2743.
1999
-
Troglitazone monotherapy improves glycemic control in patients with type 2 diabetes mellitus: a randomized, controlled study. The Troglitazone Study Group..
83:3169-3176.
1998
-
Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS)..
83:1976-1987.
1998
-
Treatment of Estrogen Deficiency Symptoms in Women Surviving Breast Cancer.
83:1993-2000.
1998
-
Cloning and Characterization of the Promoter Regions of the Human Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Gene: Analysis of Deoxyribonucleic Acid from Normal Subjects and Patients with Pseudohypoparathyroidism Type 1b.
82:1031-1040.
1997
-
A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid Hormone Versus Cyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis.
82:620-628.
1997
-
A Randomized Controlled Trial to Compare the Efficacy of Cyclical Parathyroid HormoneVersusCyclical Parathyroid Hormone and Sequential Calcitonin to Improve Bone Mass in Postmenopausal Women with Osteoporosis1.
82:620-628.
1997
-
Late luteal phase dysphoric disorder and the thyroid axis revisited.
81:2280-2284.
1996
-
Late luteal phase dysphoric disorder and the thyroid axis revisited..
81:2280-2284.
1996
-
Mortality in Canadian children with growth hormone (GH) deficiency receiving GH therapy 1967-1992. The Canadian Growth Hormone Advisory Committee.
81:1693-1696.
1996
-
2-[125I]iodomelatonin-binding sites in the human kidney and the effect of guanosine 5'-O-(3-thiotriphosphate)..
80:1560-1565.
1995
-
Melatonin receptors on human granulosa cell membranes.
80:1747-1749.
1995
-
Melatonin receptors on human granulosa cell membranes..
80:1747-1749.
1995
-
Photoperiod-driven changes in reproductive function in male rhesus monkeys..
74:1068-1074.
1992
-
Concordant Graves' Disease after Bone Marrow Transplantation: Implications for Pathogenesis.
72:837-840.
1991
-
Daily Cortisol Production Rate in Man Determined by Stable Isotope Dilution/Mass Spectrometry.
72:39-45.
1991
-
Inhibin and Estradiol Responses to Ovarian Hyperstimultion: Effects of Age and Predictive Value forin VitroFertilization Outcome.
70:358-364.
1990
-
Occult Ovarian Failure: A Syndrome of Infertility, Regular Menses, and Elevated Follicle-Stimulating Hormone Concentrations.
67:1190-1194.
1988
-
Changing Osteocalcin Concentrations During Pregnancy and Lactation: Implications for Maternal Mineral Metabolism*.
65:290-294.
1987
-
Evidence for Leydig Cell Dysfunction in Infertile Men with a Selective Increase in Plasma Follicle-Stimulating Hormone*.
64:1194-1198.
1987
-
Separate Induction of MHC and Thyroid Microsomal Antigen (McAg) Expression on Thyroid Cell Monolayers: Enhancement of Lectin-Induced McAg Expression by Interferon-γ*.
64:1302-1308.
1987
-
Gonadotropin-Independent Precocious Puberty (“Testotoxicosis”): Influence of Maturational Status on Response to Ketoconazole.
64:328-333.
1987
-
Pharmacokinetic Characteristics of the Gonadotropin-Releasing Hormone Analog D-Ser(TBU)-6EA-10Luteinizing Hormone-Releasing Hormone (Buserelin) after Subcutaneous and Intranasal Administration in Children with Central Precocious Puberty.
63:1065-1070.
1986
-
Thyrocyte HLA-DR Expression and Interferon-γProduction in Autoimmune Thyroid Disease*.
63:695-708.
1986
-
Intranasal and Subcutaneous Treatment of Central Precocious Puberty in Both Sexes with a Long-Acting Analog of Luteinizing Hormone-Releasing Hormone*.
58:966-972.
1984
-
Corticotropin-Releasing Factor: Pharmacokinetics in Man.
58:192-196.
1984
-
Altered Glucoregulatory Response to Physiological Infusions of Epinephrine and Glucagon in Hyperthyroidism*.
51:972-977.
1980
-
Glucoregulatory Response to Insulin-Induced Hypoglycemia in Laennec’s Cirrhosis.
46:778-783.
1978
-
Characteristics of Antibody Produced During Chronic Treatment with LHRH.
44:784-790.
1977
-
EFFECT OF CARBIDOPA ON PROLACTIN, GROWTH HORMONE AND CORTISOL SECRETION IN MAN.
43:236-239.
1976
-
STIMULATION OF RHESUS MONKEY GH RELEASE: ARGININE VS PLASMA VOLUME EXPANSION1.
42:169-172.
1976
-
THE SECRETION AND DISPOSITION OF CORTISOL DURING PREGNANCY*.
18:1076-1092.
1958
-
A CASE OF MASCULINIZING OVARIAN TUMOR: USE OF CORTICOSTEROID INHIBITION TEST IN DIAGNOSIS.
18:794-797.
1958
-
STUDIES ON THE ORIGIN OF ALDOSTERONE DURING HUMAN PREGNANCY*.
18:222-225.
1958
-
Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome
2013
-
Medical Management of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop
2009
-
Quantification of the soluble leptin receptor in human blood by ligand-mediated immunofunctional assay.
2002
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)